8.29
price down icon2.47%   -0.21
after-market Handel nachbörslich: 8.29
loading
Schlusskurs vom Vortag:
$8.50
Offen:
$8.26
24-Stunden-Volumen:
9.91M
Relative Volume:
0.67
Marktkapitalisierung:
$9.73B
Einnahmen:
$14.33B
Nettoeinkommen (Verlust:
$-3.79B
KGV:
-2.6151
EPS:
-3.17
Netto-Cashflow:
$1.84B
1W Leistung:
-6.22%
1M Leistung:
+6.15%
6M Leistung:
-38.00%
1J Leistung:
-21.27%
1-Tages-Spanne:
Value
$8.19
$8.31
1-Wochen-Bereich:
Value
$8.19
$8.95
52-Wochen-Spanne:
Value
$6.85
$13.55

Viatris Inc Stock (VTRS) Company Profile

Name
Firmenname
Viatris Inc
Name
Telefon
(724) 514-1465
Name
Adresse
1000 MYLAN BOULEVARD, CANONSBURG
Name
Mitarbeiter
32,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
VTRS's Discussions on Twitter

Vergleichen Sie VTRS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
8.29 10.38B 14.33B -3.79B 1.84B -3.17
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.14 48.63B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
162.58 72.59B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.84 3.27M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.57 44.08B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.96 19.43B 16.54B -1.64B 749.00M -1.45

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-19 Fortgesetzt Jefferies Buy
2023-10-23 Herabstufung BofA Securities Neutral → Underperform
2023-06-23 Herabstufung Barclays Equal Weight → Underweight
2023-04-24 Herabstufung Barclays Overweight → Equal Weight
2023-02-17 Herabstufung BMO Capital Markets Outperform → Market Perform
2023-01-27 Hochstufung Jefferies Hold → Buy
2022-11-10 Hochstufung UBS Sell → Neutral
2022-11-08 Hochstufung Piper Sandler Underweight → Neutral
2022-10-21 Fortgesetzt Jefferies Hold
2022-06-14 Eingeleitet UBS Sell
2022-05-10 Herabstufung Piper Sandler Neutral → Underweight
2022-03-01 Herabstufung BofA Securities Buy → Neutral
2022-03-01 Herabstufung Raymond James Outperform → Mkt Perform
2021-06-15 Eingeleitet Citigroup Neutral
2021-04-07 Fortgesetzt RBC Capital Mkts Outperform
2021-03-08 Herabstufung Goldman Buy → Neutral
2021-03-02 Herabstufung JP Morgan Overweight → Neutral
2021-02-26 Herabstufung Wolfe Research Outperform → Peer Perform
2021-01-05 Eingeleitet Argus Hold
2020-12-14 Eingeleitet Bernstein Mkt Perform
Alle ansehen

Viatris Inc Aktie (VTRS) Neueste Nachrichten

pulisher
04:01 AM

VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

04:01 AM
pulisher
04:00 AM

ECG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Everus Construction Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

04:00 AM
pulisher
02:25 AM

VTRS IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Viatris Inc. Investors ... - Eagle-Tribune

02:25 AM
pulisher
10:34 AM

Viatris (NASDAQ: VTRS) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit - TradingView

10:34 AM
pulisher
09:37 AM

Viatris' HIV-1 Generic Medicine Gets Backing From European Medicines Agency - marketscreener.com

09:37 AM
pulisher
09:28 AM

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

09:28 AM
pulisher
08:07 AM

VTRS FRAUD ALERT: Lose Money when Viatris Inc. Stock - GlobeNewswire

08:07 AM
pulisher
05:45 AM

Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your RightsVTRS - PR Newswire

05:45 AM
pulisher
May 22, 2025

VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit - PR Newswire

May 22, 2025
pulisher
May 22, 2025

Levi & Korsinsky Reminds Viatris Inc. Investors of the Pending Class Action Lawsuit with a ... - Eagle-Tribune

May 22, 2025
pulisher
May 22, 2025

Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView

May 22, 2025
pulisher
May 22, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - Morningstar

May 22, 2025
pulisher
May 22, 2025

Viatris to Participate in Upcoming Investor Conferences - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 3, 2025 to Discuss Your RightsVTRS - Morningstar

May 22, 2025
pulisher
May 22, 2025

VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Viatris Inc. (VTRS) LawsuitInvestors Urged to Contact Levi & Korsinsky Before June 3, 2025 - ACCESS Newswire

May 22, 2025
pulisher
May 21, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

VTRS LAWSUIT: Lose Money on Viatris Inc.? Contact BFA Law before June 3 Court Deadline - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Ex-Dividend Reminder: Evergy, Viatris and Burford Capital - Nasdaq

May 21, 2025
pulisher
May 20, 2025

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel ... - Eagle-Tribune

May 20, 2025
pulisher
May 20, 2025

DEADLINE ALERT for VTRS, CGC, and ECG: The Law Offices of - GlobeNewswire

May 20, 2025
pulisher
May 20, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming DeadlinesVTRS - PR Newswire

May 20, 2025
pulisher
May 19, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider

May 19, 2025
pulisher
May 19, 2025

DEADLINE APPROACHING: Berger Montague Advises Viatris (VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 - TradingView

May 19, 2025
pulisher
May 19, 2025

Levi & Korsinsky Reminds Viatris Inc. Investors of the - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

Viatris Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationVTRS - WV News

May 19, 2025
pulisher
May 19, 2025

Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

May 19, 2025
pulisher
May 19, 2025

Securities Fraud Class Action Filed Against Viatris Inc. (VTRS)Levi & Korsinsky Reminds Investors of June 3, 2025 - Stockhouse

May 19, 2025
pulisher
May 19, 2025

VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER ALERT Bernstein - GlobeNewswire

May 19, 2025
pulisher
May 19, 2025

VIATRIS INC. (NASDAQ: VTRS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Viatris Inc. ... - Bluefield Daily Telegraph

May 19, 2025
pulisher
May 19, 2025

Viatris, Cognizant, GE Healthcare, Netflix: Top foreign stocks that Indian mutual funds bought in April - Moneycontrol

May 19, 2025
pulisher
May 18, 2025

VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire

May 18, 2025
pulisher
May 17, 2025

Securities Class Action Lawsuit Filed Against Viatris Inc. (VTRS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire

May 17, 2025
pulisher
May 17, 2025

ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before ... - Bluefield Daily Telegraph

May 17, 2025
pulisher
May 17, 2025

ROSEN, REGARDED INVESTOR COUNSEL, Encourages Viatris Inc. - GlobeNewswire

May 17, 2025
pulisher
May 17, 2025

VTRS SHAREHOLDER NEWS: Investors of Viatris Inc. Securities - GlobeNewswire

May 17, 2025
pulisher
May 16, 2025

VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TradingView

May 16, 2025
pulisher
May 16, 2025

Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead ... - Bluefield Daily Telegraph

May 16, 2025
pulisher
May 16, 2025

Securities Lawsuit Alert: Viatris Inc. (VTRS) InvestorsContact Levi & Korsinsky Before June 3, 2025 - Stockhouse

May 16, 2025
pulisher
May 16, 2025

VTRS Lawsuit Alert! Class Action Lawsuit Against Viatris Inc. - TipRanks

May 16, 2025
pulisher
May 16, 2025

Shareholders that lost money on Viatris Inc.(VTRS) should contact Levi & Korsinsky about pending Class ActionVTRS - WV News

May 16, 2025
pulisher
May 15, 2025

Securities Lawsuit Alert: Viatris Inc. (VTRS)Contact Levi & Korsinsky Before June 3, 2025 - ACCESS Newswire

May 15, 2025
pulisher
May 15, 2025

Viatris Inc. stock rises Thursday, outperforms market - MarketWatch

May 15, 2025
pulisher
May 15, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider

May 15, 2025
pulisher
May 15, 2025

Viatris Inc. Class Action: The Gross Law Firm Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025VTRS - WV News

May 15, 2025
pulisher
May 15, 2025

Insider Buying: Scott Smith Acquires 60,000 Shares of Viatris In - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Chris Davis Increases Stake in Viatris Inc. with Significant Share Acquisition - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Chris Davis Increases Stake in Viatris Inc. with Significant Sha - GuruFocus

May 15, 2025
pulisher
May 14, 2025

VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of - Bluefield Daily Telegraph

May 14, 2025
pulisher
May 14, 2025

CEO’s Bold Move: Massive Stock Purchase Signals Confidence in Viatris - TipRanks

May 14, 2025

Finanzdaten der Viatris Inc-Aktie (VTRS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic HCM
$13.40
price up icon 0.98%
$120.18
price up icon 0.89%
drug_manufacturers_specialty_generic RDY
$14.38
price up icon 0.70%
$307.65
price down icon 0.35%
$16.96
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):